Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Current Leases (2019 - 2025)

Madrigal Pharmaceuticals (MDGL) has disclosed Current Leases for 13 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • Quarterly Current Leases rose 3.56% to $1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2025, up 3.56% year-over-year, with the annual reading at $1.0 million for FY2025, 3.56% up from the prior year.
  • Current Leases for Q4 2025 was $1.0 million at Madrigal Pharmaceuticals, down from $1.1 million in the prior quarter.
  • The five-year high for Current Leases was $1.1 million in Q3 2025, with the low at $320000.0 in Q1 2021.
  • Average Current Leases over 5 years is $671150.0, with a median of $579500.0 recorded in 2022.
  • The sharpest move saw Current Leases soared 118.11% in 2022, then crashed 53.24% in 2023.
  • Over 5 years, Current Leases stood at $410000.0 in 2021, then surged by 46.83% to $602000.0 in 2022, then decreased by 12.46% to $527000.0 in 2023, then surged by 86.53% to $983000.0 in 2024, then grew by 3.56% to $1.0 million in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $1.0 million, $1.1 million, and $1.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.